Lam Research (NASDAQ:LRCX) Stock Price Expected to Rise, Citigroup Analyst Says

Lam Research (NASDAQ:LRCX) had its price objective increased by stock analysts at Citigroup from $120.00 to $175.00 in a report released on Thursday,Benzinga reports. The brokerage currently has a “buy” rating on the semiconductor company’s stock. Citigroup’s target price suggests a potential upside of 23.89% from the company’s current price.

LRCX has been the subject of several other research reports. Hsbc Global Res upgraded Lam Research to a “hold” rating in a report on Tuesday, September 30th. Morgan Stanley increased their price objective on Lam Research from $125.00 to $137.00 and gave the stock an “equal weight” rating in a report on Thursday. Erste Group Bank began coverage on Lam Research in a report on Thursday, August 14th. They issued a “buy” rating for the company. The Goldman Sachs Group increased their price objective on Lam Research from $115.00 to $160.00 and gave the stock a “buy” rating in a report on Wednesday, October 8th. Finally, Rothschild & Co Redburn increased their price objective on Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a report on Tuesday, October 14th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have given a Buy rating and eight have given a Hold rating to the company’s stock. According to MarketBeat.com, Lam Research has a consensus rating of “Moderate Buy” and a consensus price target of $133.84.

Lam Research Trading Down 2.6%

Shares of LRCX stock opened at $141.25 on Thursday. The stock has a market capitalization of $178.12 billion, a PE ratio of 33.95, a P/E/G ratio of 1.76 and a beta of 1.84. Lam Research has a 1-year low of $56.32 and a 1-year high of $153.70. The business has a 50-day moving average of $121.38 and a 200 day moving average of $98.38. The company has a debt-to-equity ratio of 0.38, a current ratio of 2.21 and a quick ratio of 1.55.

Lam Research (NASDAQ:LRCX) last issued its earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.04. The company had revenue of $5.32 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.Lam Research’s quarterly revenue was up 27.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. As a group, sell-side analysts anticipate that Lam Research will post 3.71 earnings per share for the current year.

Insiders Place Their Bets

In related news, SVP Vahid Vahedi sold 52,190 shares of the firm’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.31% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in LRCX. Smallwood Wealth Investment Management LLC bought a new stake in shares of Lam Research in the 1st quarter worth $26,000. IMG Wealth Management Inc. purchased a new position in shares of Lam Research in the 2nd quarter worth $26,000. Howard Hughes Medical Institute purchased a new position in shares of Lam Research in the 2nd quarter worth $27,000. Strategic Wealth Investment Group LLC purchased a new position in shares of Lam Research in the 2nd quarter worth $29,000. Finally, Delos Wealth Advisors LLC purchased a new position in shares of Lam Research in the 2nd quarter worth $30,000. Institutional investors own 84.61% of the company’s stock.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.